USPH · Insider Trading
US Physical Therapy Inc
Every open-market purchase and sale reported by USPH officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-02 | Myra Davis | Director | A | +1,210 | — |
| 2026-09-15 | Nchacha Etta | EVP & Chief Financial Officer | A | +6,831 | — |
| 2026-09-14 | Peter Francis Minan | Director | Buy | +6 | +$474 |
| 2026-08-24 | Eric Joseph Williams | President and COO | F | −714 | −$55.69K |
| 2026-08-24 | Jason Travis Curtis | Interim CFO | F | −40 | −$3.12K |
| 2026-08-24 | Graham D. Reeve | COO | F | −762 | −$59.44K |
| 2026-08-24 | Richard Binstein | EVP Gen'l Counsel & Secretary | F | −450 | −$35.10K |
| 2026-06-22 | Jason Travis Curtis | Interim CFO | F | −40 | −$2.49K |
| 2026-06-22 | Graham D. Reeve | COO | F | −762 | −$47.43K |
| 2026-06-10 | Peter Francis Minan | Director | Buy | +780 | +$48.78K |
| 2026-05-28 | Peter Francis Minan | Director | A | +2,306 | — |
| 2026-05-28 | Bernard A Harris Jr | Director | A | +2,306 | — |
| 2026-05-28 | Anne Motsenbocker | Director | A | +2,306 | — |
| 2026-05-28 | Regg E. Swanson | Director | A | +2,306 | — |
| 2026-05-28 | Kathleen A Gilmartin | Director | A | +2,306 | — |
| 2026-05-20 | Kathleen A Gilmartin | Director | A | +2,306 | +$142.07K |
| 2026-05-20 | Peter Francis Minan | Director | A | +2,306 | +$142.07K |
| 2026-05-20 | Anne Motsenbocker | Director | A | +2,306 | +$142.07K |
| 2026-05-20 | Regg E. Swanson | Director | A | +2,306 | +$142.07K |
| 2026-05-20 | Bernard A Harris Jr | Director | A | +2,306 | +$142.07K |
| 2026-03-12 | Graham D. Reeve | COO | Sell | −662 | −$52.21K |
| 2026-03-11 | Graham D. Reeve | COO | Sell | −1,808 | −$148.70K |
| 2026-03-10 | Carey P Hendrickson | Chief Financial Officer | D | −10,000 | — |
| 2026-03-09 | Richard Binstein | EVP Gen'l Counsel & Secretary | Sell | −3,000 | −$244.92K |
| 2026-02-25 | Graham D. Reeve | COO | A | +10,000 | — |
| 2026-02-25 | Eric Joseph Williams | President and COO | A | +15,000 | — |
| 2026-02-25 | Richard Binstein | EVP Gen'l Counsel & Secretary | A | +10,000 | — |
| 2026-02-25 | Christopher J Reading | Chairman of the Board and CEO | A | +25,000 | — |
| 2026-02-25 | Carey P Hendrickson | Chief Financial Officer | A | +10,000 | — |
| 2025-11-25 | Graham D. Reeve | COO | Sell | −743 | −$52.76K |
| 2025-11-24 | Kathleen A Gilmartin | Director | Buy | +4,000 | +$276.00K |
| 2025-09-11 | Nancy Ham | Director | Sell | −600 | −$49.03K |
| 2025-09-08 | Eric Joseph Williams | President and COO | Sell | −1,000 | −$85.25K |
| 2025-09-05 | Christopher J Reading | Chairman of the Board and CEO | Sell | −2,000 | −$167.06K |
| 2025-08-25 | Carey P Hendrickson | Chief Financial Officer | Sell | −698 | −$60.10K |
| 2025-08-21 | Graham D. Reeve | COO | Sell | −763 | −$64.83K |
| 2025-08-19 | Richard Binstein | EVP Gen'l Counsel & Secretary | D | −2,000 | −$169.58K |
| 2025-08-12 | Graham D. Reeve | COO | Sell | −1,792 | −$155.13K |
| 2025-06-13 | Nancy Ham | Director | Sell | −400 | −$31.20K |
| 2025-05-22 | Graham D. Reeve | COO | Sell | −530 | −$41.38K |
| 2025-05-22 | Eric Joseph Williams | President and COO | Sell | −633 | −$49.43K |
| 2025-05-21 | Kathleen A Gilmartin | Director | A | +1,882 | — |
| 2025-05-21 | Anne Motsenbocker | Director | A | +1,882 | — |
| 2025-05-21 | Regg E. Swanson | Director | A | +1,882 | — |
| 2025-05-21 | Clayton Trier | Director | A | +1,882 | — |
| 2025-05-21 | Bernard A Harris Jr | Director | A | +1,882 | — |
| 2025-05-21 | Nancy Ham | Director | A | +1,882 | — |
| 2025-03-18 | Carey P Hendrickson | Chief Financial Officer | G | −63 | — |
| 2025-03-07 | Graham D. Reeve | COO | Sell | −1,730 | −$142.05K |
| 2025-02-26 | Carey P Hendrickson | Chief Financial Officer | A | +8,100 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Christopher J Reading | Chairman of the Board and CEO | 139,088 | $12.33M |
| Eric Joseph Williams | President and COO | 39,617 | $3.51M |
| Graham D. Reeve | COO | 28,554 | $2.53M |
| Carey P Hendrickson | Chief Financial Officer | 27,808 | $2.47M |
| Kathleen A Gilmartin | Director | 27,092 | $2.40M |
| Richard Binstein | EVP Gen'l Counsel & Secretary | 24,417 | $2.16M |
| Regg E. Swanson | Director | 23,088 | $2.05M |
| Bernard A Harris Jr | Director | 20,914 | $1.85M |
| Anne Motsenbocker | Director | 9,812 | $869.83K |
| Clayton Trier | Director | 8,306 | $736.33K |
| Nchacha Etta | EVP & Chief Financial Officer | 6,831 | $605.57K |
| Jason Travis Curtis | Interim CFO | 3,853 | $341.57K |
| Peter Francis Minan | Director | 3,217 | $285.20K |
| Nancy Ham | Director | 1,994 | $176.77K |
| Myra Davis | Director | 1,210 | $107.27K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the USPH quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.